Remove 2024 Remove Pharmaceutical Companies Remove Pharmaceutical Manufacturing
article thumbnail

AIPAC launches inaugural programme for MSMEs in pharma sector

Express Pharma

The All India Pharmaceutical Associations Consortium (AIPAC) launched its first programme for Micro, Small, and Medium Enterprises (MSMEs) in the pharmaceutical sector on 12 December 2024. It was designed to enhance the skills of pharmaceutical professionals and promote scientific excellence. The programme was led by S.

article thumbnail

PHARMAP 2024 held in Amsterdam, marks its fourth edition

Express Pharma

The event brought together over 330 professionals from across the industry’s value chain Pharmaceutical Manufacturing and Packaging Congress (PHARMAP 2024) was held in Amsterdam, Netherlands on April 22-23, 2024. Among the attendees, contract manufacturing organisations, service providers and experts were present.

Packaging 105
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

AI-driven drug discovery, precision medicine, and sustainable manufacturing can redefine the pharma industry

Express Pharma

What are the top 3 trends that defined pharma manufacturing in India and globally in 2024? In 2024, the pharmaceutical manufacturing landscape underwent transformative changes, driven by technological innovations, regulatory adaptations, and evolving global demands.

article thumbnail

EY Parthenon – OPPI report claims India’s pharma sector set for rapid growth

Express Pharma

Between September and October 2024, EY-P and OPPI undertook primary research * consulting top CXOs from leading Indian and global multinational pharmaceutical companies, to understand their perspective on the pivotal growth areas for the Indian pharma industry. There should be transparency in all reporting.

article thumbnail

Innovative radioligand manufacturing facility inaugurated

European Pharmaceutical Review

The first industrial-scale pharmaceutical manufacturing facility for production of lead-212-based radioligand therapies has been inaugurated. Radioligand therapy developments in 2023 and 2024 Other companies making progress producing radioligand therapies include Novartis. billion.

article thumbnail

Pharma gives UCPMP the thumbs up, health activists cry foul

Express Pharma

Health activists raise doubts on pharma associations self-monitoring the code The notification of the Uniform Code for Pharmaceutical Marketing Practices (UCPMP) 2024 on March 12 has been welcomed by major pharma associations, while health activists allege it is a “whitewash.”

article thumbnail

The Pandemic Treaty and the opportunity to end ‘vaccine apartheid’

pharmaphorum

The negotiations over the treaty are being hosted through the World Health Organization (WHO), with plans to officially adopt a binding agreement sealed by the United Nations health agency’s member countries in May 2024. The discussions over the treaty are set to continue for some time.